01.21.21 | COVID-19 TESTING WEBINAR
The COVID-19 pandemic has been the nation’s focal point for quite some time. This infectious disease has a major impact on employers, employees, and workplace safety. With so many businesses economically affected, it is important to detect any possible infections within your workforce to keep operations intact.
CRL Rapid Response™ is a saliva-based molecular RNA test that detects the SARS-CoV-2 virus and is authorized by the FDA under an Emergency Use Authorization. It is minimally invasive, easy to self-administer at home without healthcare professional assistance. Results are generally provided on the Frasco® Profiles portal, ISLA, within 48 hours of sample receipt.